Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN gastrointestinal disorder
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Optometry graduate Alex Fenson launching career in vision therapy
Fenson, who competed in the Olympic trials for curling while starting optometry school, plans to bring needed care to his hometown of Bemidji, Minnesota.
MORE IN gastrointestinal disorder
LATEST NEWS
- Optometry graduate Alex Fenson launching career in vision therapy
- 3 questions with John Ampomah, master’s student in criminology and criminal justice
- UMSL College of Optometry launches partnership with Kansas City University Biomedical Sciences Program
- Returning to her roots: Lúcia Lohmann takes over leadership of Missouri Botanical Garden
- AACSB renews College of Business Administration’s dual accreditation for all business and accounting programs
- Upcoming BSN graduate Miranda Martin lands position as operating room nurse at SSM Health DePaul Hospital
- Succeed+ student Jaylin Brown meets with legislators in Washington to advocate for postsecondary education
- UMSL hosts Midwest Ecology and Evolution Conference
- Undergraduate Research Symposium provides forum for students to share deeper learning
- Eye on UMSL: Lifting her voice
